Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients.

Dong Yeon Kim Sung Woo Cho Kyu Tae Park Jong-Hwa Ahn Taek Kyu Park Yong Ho Jang Ki Hong Choi Joo-Myung Lee Jeong Hoon Yang Young Bin Song Jin Ho Choi Seung-Hyuk Choi Hyeon Cheol Gwon Sang Hoon Lee Joo-Yong Hahn

Published in: Journal of Korean medical science (2021)

Compared with prolonged DAPT, clopidogrel monotherapy showed similar long-term outcomes in patients at high-risk after second-generation DES implantation.

Keyphrases

antiplatelet therapy
percutaneous coronary intervention
acute coronary syndrome
end stage renal disease
st segment elevation myocardial infarction

acute myocardial infarction
ejection fraction
newly diagnosed
chronic kidney disease
coronary artery disease

peritoneal dialysis
prognostic factors
coronary artery bypass grafting
heart failure

combination therapy
atrial fibrillation
clinical trial
patient reported